GSDMD and Parkinson disease: A recent study showed that Prussian blue nanozyme (PBzyme) inhibited the upstream ROS-NLRP3-GSDMD pathway and microglia pyroptosis, thereby reducing dopaminergic degeneration, neuroinflammation, and motor dysfunction in the MPTP-induced PD mouse model (118).